Literature DB >> 20932265

Atherosclerotic coronary heart disease-epidemiology, classification and management.

Smita Negi1, Aashish Anand.   

Abstract

Atherosclerotic coronary heart disease (CHD) is a major health problem worldwide. Epidemiological studies have identified the role of several modifiable and non-modifiable risk factors in the pathogenesis of CHD. Aggressive risk modification has led to a significant improvement in the morbidity and mortality from CHD. However, there is a growing need to identify better modalities of risk prediction in CHD. Many of these newer risk markers, currently under evaluation, are based on the newer concept that atherosclerosis is more than merely a problem of lipid imbalance. There has been a recent shift in the paradigm towards inflammation and oxidative stress as the key drivers in the pathophysiology of atherosclerosis and its complications. Further understanding of this complex interplay of lipid and inflammatory factors is likely to pave way to a better understanding of this disease and its myriad complications.

Entities:  

Mesh:

Year:  2010        PMID: 20932265     DOI: 10.2174/187152910793743832

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  13 in total

1.  Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody.

Authors:  Yosdel Soto; Niurka Mesa; Yumisley Alfonso; Arlenis Pérez; Fernando Batlle; Tania Griñán; Adonis Pino; Justo Viera; Milagros Frómeta; Victor Brito; Armando Olivera; Francisco Zayas; Ana M Vázquez
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

Review 2.  Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.

Authors:  Yinan Hua; Sreejayan Nair
Journal:  Biochim Biophys Acta       Date:  2014-05-09

3.  Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population.

Authors:  FengHe Cui; KeZhong Li; YunFeng Li; XueWu Zhang; ChangShan An
Journal:  Lipids Health Dis       Date:  2014-11-08       Impact factor: 3.876

4.  CYP2J2 participates in atherogenesis by mediating cell proliferation, migration and foam cell formation.

Authors:  Rui Li; Yuan Zhang; Huacheng Yan; Hua Xiao; Yunjun Ruan; Jian Qiu; Lei Shi
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

5.  Network Pharmacology Study on Molecular Mechanisms of Zhishi Xiebai Guizhi Decoction in the Treatment of Coronary Heart Disease.

Authors:  Jin Gao; Yujing Pan; Yuxi Zhao; Haoyang Li; Zishuo Mi; Hao Chen; Xiaodong Tan
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-20       Impact factor: 2.629

6.  MicroRNA-34a in coronary heart disease: Correlation with disease risk, blood lipid, stenosis degree, inflammatory cytokines, and cell adhesion molecules.

Authors:  Hefei Li; Mingchao Chen; Qiang Feng; Lin Zhu; Zhichao Bai; Boya Wang; Zhangli Guo; Aijun Hou; Hui Li
Journal:  J Clin Lab Anal       Date:  2021-12-03       Impact factor: 2.352

7.  Meta-analysis of the association of the rs2234693 and rs9340799 polymorphisms of estrogen receptor alpha gene with coronary heart disease risk in Chinese Han population.

Authors:  Chuan-Dong Wei; Hong-Yun Zheng; Wei Wu; Wen Dai; Yong-Qing Tong; Ming Wang; Yan Li
Journal:  Int J Med Sci       Date:  2013-03-02       Impact factor: 3.738

8.  Serum Gamma-glutamyl Transferase Concentration Within the Reference Range is Related to the Coronary Heart Disease Risk Prediction in Korean Men: Analysis of the Korea National Health and Nutrition Examination Survey (V-1, 2010 and V-2, 2011).

Authors:  Kyung-Sun Han; Doo-Yeoun Cho; Young-Sang Kim; Kyu-Nam Kim
Journal:  Chin Med J (Engl)       Date:  2015-08-05       Impact factor: 2.628

9.  ICAM-1 and MKL-1 polymorphisms impose considerable impacts on coronary heart disease occurrence.

Authors:  Cungang Wu; Chao Huang
Journal:  J Cell Mol Med       Date:  2020-08-07       Impact factor: 5.310

10.  Association between circular RNA expression content and severity of coronary atherosclerosis in human coronary artery.

Authors:  Can Hou; Lingfeng Gu; Yi Guo; Yaqing Zhou; Lei Hua; Jiaxin Chen; Shu He; Sheng Zhang; Qiaowei Jia; Chenhui Zhao; Jing Zhang; Guangxu Xu; Enzhi Jia
Journal:  J Clin Lab Anal       Date:  2020-09-05       Impact factor: 3.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.